Global Cord Blood Corp
OTC:CORBF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| HK |
|
Global Cord Blood Corp
OTC:CORBF
|
127.7m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
75.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
61.7B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.1B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD |
Loading...
|
Market Distribution
| Min | -3 900% |
| 30th Percentile | 12.5% |
| Median | 26.6% |
| 70th Percentile | 42.7% |
| Max | 905% |
Other Profitability Ratios
Global Cord Blood Corp
Glance View
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,215 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Global Cord Blood Corp’s Gross Margin has increased from 81.1% to 85.2%. During this period, it reached a low of 81.1% on Mar 3, 2019 and a high of 85.2% on May 1, 2022.
